Schedule 13G ownership disclosure
BOUNDLESS BIO INC
COMMON STOCK · CUSIP: 10170A100
Event date: 2025-12-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- FMR LLC
Shares: 2,684,022.00 · Class: 12.0%
- Abigail P. Johnson
Shares: 2,684,022.00 · Class: 12.0%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000315066-26-000366
- Form type
- SCHEDULE 13G/A
- Filer
- Boundless Bio, Inc.
- CIK
- CIK 1782303
- Filed
- Feb 05, 2026
- Reporting period
- Dec 31, 2025
- Description
- Schedule 13G beneficial ownership